Altre lingue Zhejiang CONBA Pharmaceutical Co.,Ltd.

Azioni

600572

CNE000001H86

Prezzo di chiusura Shanghai S.E. Altri mercati azionari 00:00:00 30/04/2024			Variaz. 5gg	Var. 1 gen.
4,94 ^CNY	+0,41%		+0,61%	-2,18%

26/04	Zhejiang CONBA Pharmaceutical Co.,Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
19/04	Zhejiang CONBA Pharmaceutical Co.,Ltd. Riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	19/04
Tranche Update on Zhejiang CONBA Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on January 23, 2024.	01/04
Shanghai-Listed Firms Actively Repurchase Shares as Regulators Focus on Market Value	02/02
Shanghai Dingjia Trading Co., Ltd. agreed to acquire 20% stake in Shanghai Kede Network Technology Co., Ltd. from Zhejiang CONBA Pharmaceutical Co.,Ltd. for CNY 26 million.	01/02
Zhejiang CONBA Pharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 400 million worth of its shares.	23/01
Zhejiang CONBA Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.	22/01
CONBA Pharma Gets Nod to Trial Cough Medicine	28/11
CONBA Pharma Unit's Acetyl Cysteine Granules Chosen for China's Centralized Drug Procurement	08/11
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Zhejiang CONBA Pharmaceutical Co.,Ltd.(XSSC:600572) added to S&P Global BMI Index	18/09/23
Zhejiang CONBA Pharmaceutical Co.,Ltd.(XSSC:600572) added to FTSE All-World Index	18/09/23
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	04/08/23
Wuxi China Life Chengda Equity Investment Center (Limited Partnership) and Jinhua Future Yicai Phase I Equity Investment Partnership (Limited Partnership) completed the acquisition of 7.84% stake in Jiangxi Zhenshiming Pharmaceutical Co., Ltd. from Zhejiang CONBA Pharmaceutical Co.,Ltd.	07/07/23
CONBA Pharma Gets Drug Registration for Risperidone Oral Solution	25/05/23
Wuxi China Life Chengda Equity Investment Center (Limited Partnership) and Jinhua Future Yicai Phase I Equity Investment Partnership (Limited Partnership) intends to acquire 7.84% stake in Jiangxi Zhenshiming Pharmaceutical Co., Ltd. from Zhejiang CONBA Pharmaceutical Co.,Ltd for CNY 290 million.	29/04/23
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	18/04/23
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	14/04/23
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	14/04/23
Zhejiang CONBA Pharmaceutical to Sell 7.8% Stake in Pharma Firm	20/03/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Zhejiang CONBA Pharmaceutical Co.,Ltd.

Azioni

600572

CNE000001H86

Altre lingue

Filtri